Literature DB >> 17548550

A pilot randomized education rehabilitation trial is feasible in sickle cell and strokes.

A A King1, D A White, R C McKinstry, M Noetzel, M R Debaun.   

Abstract

A randomized trial was completed to assess the feasibility of a 2-year education rehabilitation program for students with sickle cell disease and memory deficits. Eleven students were assigned to tutoring with or without memory training for 2 years. Eighty-two percent completed the program. Evidence of improvement in memory and academic achievement existed. Educational rehabilitation is a feasible strategy, but further investigation is needed to assess the benefit in a multi center trial.

Entities:  

Mesh：

Year:  2007        PMID： 17548550     DOI： 10.1212/01.wnl.0000264421.24415.16

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  10 in total

Review 1.  The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease.

Authors:  John J Strouse; Sophie Lanzkron; Victor Urrutia
Journal:  Expert Rev Hematol       Date:  2011-12       Impact factor: 2.929

Review 2.  Postintensive Care Syndrome in Pediatric Critical Care Survivors: Therapeutic Options to Improve Outcomes After Acquired Brain Injury.

Authors:  Cydni N Williams; Mary E Hartman; Kristin P Guilliams; Rejean M Guerriero; Juan A Piantino; Christopher C Bosworth; Skyler S Leonard; Kathryn Bradbury; Amanda Wagner; Trevor A Hall
Journal:  Curr Treat Options Neurol       Date:  2019-09-27       Impact factor: 3.598

Review 3.  Sickle cell disease and implementation science: A partnership to accelerate advances.

Authors:  Allison A King; Ana A Baumann
Journal:  Pediatr Blood Cancer       Date:  2017-05-28       Impact factor: 3.167

Review 4.  Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia.

Authors:  Michael R DeBaun; F Daniel Armstrong; Robert C McKinstry; Russell E Ware; Elliot Vichinsky; Fenella J Kirkham
Journal:  Blood       Date:  2012-02-21       Impact factor: 22.113

Review 5.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

Review 6.  Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.

Authors:  Monika R Asnani; Kim R Quimby; Nadia R Bennett; Damian K Francis
Journal:  Cochrane Database Syst Rev       Date:  2016-10-06

Review 7.  Cerebrovascular disease and stroke.

Authors:  J Pappachan; F J Kirkham
Journal:  Arch Dis Child       Date:  2008-06-30       Impact factor: 3.791

8.  Remote Technology-Based Training Programs for Children with Acquired Brain Injury: A Systematic Review and a Meta-Analytic Exploration.

Authors:  Claudia Corti; Viola Oldrati; Maria Chiara Oprandi; Elisabetta Ferrari; Geraldina Poggi; Renato Borgatti; Cosimo Urgesi; Alessandra Bardoni
Journal:  Behav Neurol       Date:  2019-08-01       Impact factor: 3.342

9.  The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains.

Authors:  Macy L Early; Elizabeth Linton; Allison Bosch; Timothy Campbell; Felicia Hill-Briggs; Lydia H Pecker; Eboni I Lance; Sophie Lanzkron
Journal:  Br J Haematol       Date:  2022-04-06       Impact factor: 8.615

10.  American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.

Authors:  M R DeBaun; L C Jordan; A A King; J Schatz; E Vichinsky; C K Fox; R C McKinstry; P Telfer; M A Kraut; L Daraz; F J Kirkham; M H Murad
Journal:  Blood Adv       Date:  2020-04-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.